Cindy L. O’Bryant
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes 5
- Oncology top 5%
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 8
- Pancreatic and Hepatic Oncology Research 6
- HER2/EGFR in Cancer Research 6
- Family Practice top 5%
- Cancer Research top 10%
-
- Lung Cancer Treatments and Mutations 7
-
- Chemotherapy-induced organ toxicity mitigation 7
-
- Angiogenesis and VEGF in Cancer 6
Cindy L. O’Bryant
67 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Geriatrics and Gerontology 129
- Oncology 738
- Family Practice 52
- Cancer Research 220
- Pulmonary and Respiratory Medicine 471
Countries citing papers authored by Cindy L. O’Bryant
This map shows the geographic impact of Cindy L. O’Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy L. O’Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy L. O’Bryant more than expected).
Fields of papers citing papers by Cindy L. O’Bryant
This network shows the impact of papers produced by Cindy L. O’Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy L. O’Bryant. The network helps show where Cindy L. O’Bryant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cindy L. O’Bryant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2021 | 11 | |
| 5 | 2020 | 3 | |
| 6 | 2020 | 1 | |
| 7 | 2018 | 29 | |
| 8 | 2017 | 24 | |
| 9 | 2016 | 1 | |
| 10 | 2015 | 5 | |
| 11 | 2012 | 134 | |
| 12 | 2011 | 52 | |
| 13 | 2008 | 19 | |
| 14 | 2008 | 29 | |
| 15 | 2008 | 23 | |
| 16 | 2008 | 19 | |
| 17 | 2008 | 7 | |
| 18 | A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors and lymphoma | 2007 | 3 |
| 19 | 2007 | 22 | |
| 20 | 2005 | 28 |
About Cindy L. O’Bryant
Cindy L. O’Bryant is a scholar working on Geriatrics and Gerontology, Oncology and Transplantation, having authored 68 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers), Chemotherapy-induced organ toxicity mitigation (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), HER2/EGFR in Cancer Research (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). The work is most often cited by research in Geriatrics and Gerontology (129 citations), Oncology (738 citations) and Family Practice (52 citations). Cindy L. O’Bryant has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lia Gore, D. Ross Camidge, Laura Q.M. Chow, Sami Diab, Bonnie Ky, JoAnn Lindenfeld, Davy Cheng, Robert L. Page, C. Michael Stein and Robin J. Trupp. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.